Early detection of pancreatic cancer using fluid from the upper gut
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study collects fluid from the first part of the small intestine (duodenum) during an endoscopy to see if it can help detect pancreatic cancer early. It is for people who already need an endoscopy for medical reasons.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You are already scheduled for an upper endoscopy, endoscopic ultrasound, or ERCP as part of your medical care.
- You have either been diagnosed with pancreatic ductal adenocarcinoma (stage I–IV) OR imaging suggests you may have pancreatic cancer and you are scheduled for a biopsy.
- If you do not have pancreatic cancer, you may have a pancreatic cyst or pancreatitis, or you have no known pancreatic disease.
- You must be medically stable and able to undergo endoscopy safely.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood samples from people with early-stage pancreatic cancer to understand how the immune system behaves. The goal is to find better treatments. If you have pancreatic cancer that hasn't spread, they may ask you to donate blood for research.
This study looks at “tumor regulatory molecules,” which are substances that may be released by cancer, to improve early pancreatic cancer detection. You may join if you have early, localized pancreatic cancer that can be treated with surgery, or certain pancreatic cysts/fluid collections where doctors are investigating further.
This study tests LINFU™, a noninvasive method to collect pancreatic cells to help detect pancreatic cancer earlier. You may be invited if you’re at higher risk or you have concerning symptoms and planned pancreas/bile testing (like EUS or CT).
This study is collecting information from people who may have pancreatic cancer to see how a new ultrasound imaging technique (called LINFU) works for helping doctors decide whether a biopsy is needed. Participation could provide better imaging to guide your care.
This study uses a special endoscopic ultrasound to screen people at high risk for pancreatic cancer and follows them over time to catch cancer early or prevent it. If you have certain risk factors, you may be eligible to join.
This study tests a new lab test called PanCystPro that looks at fluid taken from a pancreatic cyst during an endoscopic ultrasound. It aims to help doctors better manage your condition.
Hear when a new Pancreatic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.